TargTex

TargTex is a portuguese biotech company that is developing a specific inhibitor of an unexplored target for the treatment of Glioblastoma Multiforme.

[TargTex @TargTex]

Major achievement: #TargTex hydrogel-based treatment for #Glioblastoma was granted Orphan Drug Designation from the #FDA for the treatment of malignant #Gliomas.

https://t.co/hmdHXdUQQF

[TargTex @TargTex]

July 19th 2023 is #GBMDay. At @TargTex we are committed to develop our innovative #GBM treatment and support patients, their families and caregivers defeating this terrible disease!

[TargTex @TargTex]

Happy to announce a new partnership with Image Analysis Group, to support our GBM clinical trial with advanced AI-based Imaging tools!

https://t.co/BmfqhZQHP9

[TargTex @TargTex]

Last day at #bioeurope2022 about to start! Great event so far.
#partnering #fundraising

[TargTex @TargTex]

Attending ESMO 2022 in Paris!

[TargTex @TargTex]

July 20th 2022 is GBM Awareness Day. Our commitment is to defeat the most common and deadliest type of brain cancer!
#GBMDay #defeatGBM

[TargTex @TargTex]

Today we meet entrepreneurs, investors, start-ups and other companies at the Startup Capital Summit in the beautiful and sunny city of Coimbra!
https://t.co/ZTBzEJ8UW7

[TargTex @TargTex]

Awesome news: TargTex announces a € 2M Seed Extension investment round from Laboratórios Basi, a portuguese pharmaceutical company from the FHC Group! Check our website for more details!

[Nanoform @NanoformF]

We are pleased to announce that we have signed a GMP manufacturing program (clinical development) to enhance @TargTex’s glioblastoma multiforme drug candidate. 

This follows a successful Proof of Concept study. Learn more: https://t.co/OwZSaEZcYW

[TargTex @TargTex]

Our co-founder and Scientific Director @gbernardes_chem was a finalist of the 2022 Blavatnik Awards in the UK!!🏆🏆🏆 Congratulations Gonçalo!

[Blavatnik Awards @BlavatnikAwards]

Announcing the 2022 Blavatnik Awards in the UK 🇬🇧 Finalists 🏅 🏅 🏅 ! @gbernardes_chem @ChemCambridge @IMMolecular @SPThomasGroup @volcanofile @Cambridge_Uni @EdinburghChem @EdinburghUni @sarahhaigh_mcr @OfficialUoM

https://t.co/tSbi7sRfo5

#Blavatnik2022

[TargTex @TargTex]

Just a few hours to kick off the 3rd Glioblastoma Drug Development Summit. Meet our CEO João Seixas and listen to TargTex presentation
@GbmSummit

https://t.co/rZqrCIWjRJ

[TargTex @TargTex]

Happy birthday to us!! Today TargTex celebrates 2 years! Many challenges, many achievements and strongly committed to bring a new therapy to Glioblastoma patients!

[TargTex @TargTex]

Kick-off: Starting Day 1 at the AACR2021 meeting.

[TargTex @TargTex]

Great news. TargTex was considered one of the Top Presenting Companies at the European Healthtech Investment Forum 2021, held by TechTour in Finland last week.
#techtour #businessfinland

[TargTex @TargTex]

Starting Day 2 at BioEurope Spring Edition 2021!

#BIOEuropeSpring

[TargTex @TargTex]

Day 1 at BioEurope Spring Edition. Ready to start!!

[TargTex @TargTex]

TargTex is today pitching at the European Healthtech Investment Forum 2021 in Finland!

[TargTex @TargTex]

Less than 24h to attend the 2nd Glioblastoma Drug Development Summit 2020! Excellent opportunity to meet GBM experts and KOLs. #GBMSummit #tacklingGBM

[TargTex @TargTex]

TargTex, a startup portuguesa que está a criar um gel para curar tumores cerebrais https://t.co/aBiNM0rYcP

[TargTex @TargTex]

Looking forward to attend the first Glioblastoma Drug Development Summit starting tomorrow in Boston!